Help us: Donate
Follow us on:
×

Menu

Back

Tag: Reason

EARD2021 Reason
At Ending Age-Related Diseases 2021, Reason, the CEO of Repair Biotechnologies, discussed a new method of enabling macrophages to consume cholesterol without turning into foam cells and dying. Script These days, we are much more focused on cardiovascular disease. The thymus is an area of interest for me and something I will be returning to...
Reason, author of the anti-aging blog Fight Aging and CEO of Repair Biotechnologies, still isn't convinced that methylation is very useful in assessing biological age or the efficacy of various therapeutics, despite the wide use of methylation-based clocks. He surprised me at this year's Longevity Therapeutics conference in San Francisco by speaking out about the...
On July 11-12th, we return to the Cooper Union in New York City for our second annual Ending Age-Related Diseases conference, which focuses on the progress in aging research as well as the business side of biotech. We will be bringing you the latest aging research, investment, and business knowledge from some of the top...
Today, we present an interview with Reason, the editor of Fight Aging! and co-founder of Repair Biotechnologies. We asked him about the state of rejuvenative therapies, some of which may be available in the near future. Fight Aging! was the first blog that tackled the science of aging in a serious fashion. Many people still...
RAADFest, which is held every year in San Diego, California, is one of a growing number of conferences focused on longevity and how to slow or reverse the processes of aging. This was the third RAADFest, and it was, as in years past, an interesting mix of science conference and almost-religious rally and party. The...
Most people interested in rejuvenation and life extension are familiar with Fight Aging!, one of the very first rejuvenation advocacy blogs dating back all the way to the early 2000s; if you're one of them, then you certainly are familiar with Reason, the man behind FA!. Over the years, Reason has been a patient yet...